English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  51792664    線上人數 :  1064
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"lu s n"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 41-50 / 140 (共14頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2022-02-22T05:34:12Z Hepatitis C virus core antigen is cost-effective in community-based screening of active hepatitis C infection in Taiwan Wang J.-H.; CHIEN-HUNG CHEN; Chang C.-M.; Feng W.-C.; Lee C.-Y.; Lu S.-N.
臺大學術典藏 2022-02-22T05:34:11Z Real-world effectiveness of glecaprevir/pibrentasvir and ledipasvir/sofosbuvir for mixed genotype hepatitis C infection: A multicenter pooled analysis in Taiwan Chiu W.-N.; Hung C.-H.; Lu S.-N.; Chen M.-Y.; Tung S.-Y.; Wei K.-L.; Lu C.-K.; CHIEN-HUNG CHEN; Hu T.-H.; Hu J.-H.; Chen W.-M.; Chang T.-S.
臺大學術典藏 2022-02-22T05:34:11Z Liver stiffness-based score at sustained virologic response predicts liver-related complications after eradication of hepatitis C virus Kuo Y.-H.; Kee K.-M.; Hung C.-H.; Lu S.-N.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H.
臺大學術典藏 2022-02-22T05:34:10Z Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; CHIEN-HUNG CHEN; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Hsu C.; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group
臺大學術典藏 2022-02-22T05:34:08Z How may ramucirumab help improve treatment outcome for patients with gastrointestinal cancers? Chen M.-H.; Lu S.-N.; CHIEN-HUNG CHEN; Lin P.-C.; Jiang J.-K.; D’yachkova Y.; Lukanowski M.; Cheng R.; Chen L.-T.
臺大學術典藏 2022-02-22T05:34:08Z Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H.
臺大學術典藏 2022-02-22T05:34:07Z Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis (Front. Oncol., (2021), 11, (737767), 10.3389/fonc.2021.737767) Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H.
臺大學術典藏 2022-02-18T08:26:09Z Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: A community-based long-term prospective study Lee M.-H.; Yang H.-I.; Lu S.-N.; Jen C.-L.; You S.-L.; Wang L.-Y.; Wang C.-H.; Chen W.J.; Chen C.-J.; Hsieh C.Y.; Lee H.S.; Yang P.M.; Chen C.H.; Chen J.D.; Huang S.P.; Jan C.F.; Chen T.H.H.; Sun C.A.; Wu M.H.; Chen S.Y.; Chu K.E.; Ho S.C.; Lu T.G.; Wu W.P.; Ou T.Y.; Lin C.G.; Shih K.C.; Chung W.S.; Li C.; CHIEH-CHANG CHEN; How W.C.
臺大學術典藏 2022-02-18T08:26:03Z Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients Lee M.-H.; Huang C.-F.; Lai H.-C.; Lin C.-Y.; Dai C.-Y.; Liu C.-J.; Wang J.-H.; Huang J.-F.; Su W.-P.; Yang H.-C.; Kee K.-M.; Yeh M.-L.; Chuang P.-H.; Hsu S.-J.; Huang C.-I.; Kao J.-T.; CHIEH-CHANG CHEN; Chen S.-H.; Jeng W.-J.; Yang H.-I.; Yuan Y.; Lu S.-N.; Sheen I.-S.; Liu C.-H.; Peng C.-Y.; Kao J.-H.; Yu M.-L.; Chuang W.-L.; Chen C.-J.
臺大學術典藏 2022-01-25T05:10:33Z HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; CHI-LING CHEN; Kao J.-H.; Lai M.-Y.; Liu C.-H.; Su T.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Chen P.-J.; Liu C.-J.; Chen D.-S.

顯示項目 41-50 / 140 (共14頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目